Glucagon-Like Peptide-1 Receptor Agonists Added to Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Historical Cohort Study Using the Diabetes Study From the Center of Tokyo Women's Medical University (DIACET)
Tokyo Women's Medical University Journal · 2023-11 · 7 · 82-92
DOI: 10.24488/twmuj.2023005 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Tokyo Women's Medical University Journal, 2023-11. Verfasst von Tetsuya Babazono und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
This study clarifies the effects of adding a glucagon-like peptide-1 receptor agonist (GLP-1RA) to sodium-glucose cotransporter 2 inhibitor (SGLT2i) therapy on glycated hemoglobin (HbA1c) and body weight in Japanese patients with type 2 diabetes (T2D).
Methods
This historical cohort study, part of the Diabetes Study from the Center of Tokyo Women's Medical University, included 80 adults with T2D (registered April 2014-July 2020) prescribed SGLT2i for ≥3 months before adding GLP-1RA. HbA1c and weight changes to 12 months after GLP-1RA prescription were assessed, overall and in subgroups based on previous dipeptidyl peptidase-4 inhibitor use, body mass index (BMI), baseline HbA1c levels, and insulin use.
Results
HbA1c was significantly reduced from baseline (mean ± SD: 8.9 ± 1.6%) at all times, including 6 months (primary endpoint: 8.2 ± 1.3%; change: −0.76%, P = 0.002). At 12 months, 21.4% of individuals achieved HbA1c levels
Schlagwörter
Zitieren
APA
Babazono, T., Murata, H., Sato, M., & Takeuchi, M. (2023). Glucagon-Like Peptide-1 Receptor Agonists Added to Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Historical Cohort Study Using the Diabetes Study From the Center of Tokyo Women's Medical University (DIACET). Tokyo Women's Medical University Journal, 7(0), 82-92. https://doi.org/10.24488/twmuj.2023005
Vancouver
Babazono T, Murata H, Sato M, Takeuchi M. Glucagon-Like Peptide-1 Receptor Agonists Added to Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Historical Cohort Study Using the Diabetes Study From the Center of Tokyo Women's Medical University (DIACET). Tokyo Women's Medical University Journal. 2023;7(0):82-92. doi:10.24488/twmuj.2023005
BibTeX
@article{Babazono2023,
author = {Babazono, Tetsuya and Murata, Hidekazu and Sato, Manaka and Takeuchi, Masakazu},
title = {Glucagon-Like Peptide-1 Receptor Agonists Added to Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes: A Historical Cohort Study Using the Diabetes Study From the Center of Tokyo Women's Medical University (DIACET)},
journal = {Tokyo Women's Medical University Journal},
year = {2023},
volume = {7},
number = {0},
pages = {82--92},
doi = {10.24488/twmuj.2023005}
}
EUVIMED